002371.SZ (002371.SZ)

$324.6B
Market Cap
51.4
P/E Ratio
-0.18
Beta
0.17%
Dividend Yield
Piotroski 6/9Altman Z 7.3 SafeROIC−WACC +4.5%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 7.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency demonstrates a robust ROIC-WACC spread of 4.5%, indicating that the firm generates returns on invested capital significantly above its cost of equity, which typically signals high-quality economic moats despite unknown sector dynamics. This profitability is underpinned by superior margin expansion rather than operational leverage or balance sheet magnification; specifically, an 18.8% net margin and a dominant 42.9% gross margin suggest strong pricing power or low variable costs, while the DuPont decomposition points to margins as the primary ROE driver given the absence of explicit turnover or leverage data in the provided metrics. Financial distress risk appears negligible with an Altman Z-Score of 7.3, well within safe territory, and operational stability is further corroborated by a Piotroski F-Score of 6/9, reflecting solid fundamentals without reaching the maximum strength threshold often associated with aggressive growth transitions.

Valuation metrics present a significant divergence between current market pricing and historical norms or peer benchmarks, as evidenced by a forward P/E ratio of 51.4x. This premium multiple implies that investors are pricing in substantial future earnings acceleration; however, such high valuations require sustained execution to justify the cost basis, particularly when compared against typical sector averages which usually trade at more moderate multiples unless the company operates in an ultra-growth niche with exceptional scalability. The current market consensus appears anchored on the trajectory of 35.1% year-over-year revenue growth, suggesting that any deceleration could trigger a rapid re-rating downward as the gap between implied and realized performance widens.

The risk-reward profile hinges critically on whether this hyper-growth phase can be maintained without eroding the already impressive margin structure or triggering a valuation contraction if market sentiment shifts toward mean reversion. While the strong Z-Score mitigates bankruptcy concerns, the elevated P/E leaves little room for error regarding future growth assumptions, creating a scenario where downside volatility could accelerate faster than upside potential during periods of macroeconomic tightening or sector-specific headwinds.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
7.3
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

42.9%
Gross Margin
18.8%
Net Margin
12.5%
ROIC
8.0%
WACC
ROIC − WACC Spread: +4.5%— Positive spread.
+35.1%
Revenue Growth (YoY)
+44.2%
Earnings Growth (YoY)
-473.0M
Free Cash Flow

Balance Sheet Health

1.04x
Debt / Equity
1.97x
Current Ratio
38.5x
Interest Coverage
-1.1x
Net Debt / EBITDA
-0.15%
FCF Yield
7.7B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $1.65
Act: $1.81
+9.9%
Q3
✓ Beat
Est: $1.50
Act: $2.18
+44.9%
Q2
✗ Miss
Est: $2.47
Act: $2.23
-9.5%
Q1
✗ Miss
Est: $2.86
Act: $2.64
-7.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

34.8
Forward P/E
PEG Ratio
9.00
Price/Book
9M
Avg Volume
$534.00
52W High
$297.10
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in 002371.SZ to visualize passive redemption contagion across ETFs and collateral stocks.

002371.SZ Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
002371.SZEpicenterLITETFRIOLow Risk006400.KSUnknownALBMed Risk6752.TMed Risk002460.SZMed Risk
002371.SZ Price Drop (%)0

If 002371.SZ (002371.SZ) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Rio Tinto PLC ADR (RIO) as the most exposed collateral stock, sharing 1 ETFs with 002371.SZ. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

002371.SZ Ownership Dynamics

Ticker
002371.SZ

ETFs with Highest 002371.SZ Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

002371.SZ Capital Efficiency

How efficiently does 002371.SZ convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$-472,989,202.56
EBITDA
$7.7B
FCF Conversion
-6%
Reinvestment Rate
106%
-6% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
12.5%
ROIC − WACC Spread
4.6%

002371.SZ converts -6% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 106% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 4.6% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare 002371.SZ to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.